Free shipping on all orders over $ 500

MK-0752

Cat. No. M2120

All AbMole products are for research use only, cannot be used for human consumption.

MK-0752 Structure
Size Price Availability Quantity
5mg USD 155  USD155 In stock
10mg USD 240  USD240 In stock
50mg USD 635  USD635 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MK-0752 is a potent gamma secretase inhibitor, an enzyme required for Notch pathway activation. MK-0752 reduces Aβ40 production with IC50 of 5 nM in human SH-SY5Y cells. MK-0752 blocks Notch-intracellular domain (ICD) cleavage and its subsequent nuclear translocation in vitro. MK-0752 treatment increases levels of Aβ 1-14, Aβ 1-15 and Aβ 1-16, while decreases levels of Aβ 1-17. Phase I clinical trials has been completed in 2006, and the results reported showed that MK-0752 was well-tolerated in a limited number of patients below 300 mg/m2, and further enrollment was underway to establish the MTD.

Customer Product Validations & Biological Datas
Source Oncol Lett (2016). Figure 2. MK-0752
Method Flow cytometric analysis
Cell Lines T‑cell
Concentrations 50 μM
Incubation Time 48 h
Results Furthermore, the second GSI MK.0752, which is currently under clinical evaluation for various cancer types, also significantly enhanced TRAIL.induced apoptosis in T.ALL cells
Chemical Information
Molecular Weight 442.9
Formula C21H21ClF2O4S
CAS Number 471905-41-6
Solubility (25°C) DMSO 79 mg/mL
Ethanol 35 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Krop I, et al. J Clin Oncol. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.

[2] Fouladi M, et al. J Clin Oncol. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

[3] Harrison H, et al. Cancer Res. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

Related Gamma-secretase/Beta-secretase Products
Nirogacestat dihydrobromide

Nirogacestat dihydrobromide (PF-3084014 dihydrobromide) is a reversible, orally bioavailable, noncompetitive, and selective γ-secretase inhibitor with an IC50 of 6.2 nM.

RE(EDANS)EVNLDAEFK(DABCYL)R

RE (EDANS) EVNLDAEFK (DABCYL) R is an EDANS and DABCYL double-labeled peptide,serves as a fluorescent substrate for BACE1(Em=360nm,Ex=528nm).

β-Secretase inhibitor

β-Secretase inhibitor ([Asn670, Sta671, Val672]-Amyloid β Peptide (662-675)) is a β-secretase and BACE1 inhibitor (IC50: 25 nM for β-secretase).

Mca-SEVNLDAEFK(Dnp)

Mca-SEVNLDAEFK(Dnp) is a Beta-secretase 1 (BACE-1) peptide FRET substrate, containing the 'Swedish' Lys-Met/Asn-Leu mutation of the amyloid precursor protein (APP) β-secretase cleavage site.

BACE1-IN-10

BACE1-IN-10 is a potent BACE1 Inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: MK-0752 supplier, Gamma-secretase/Beta-secretase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.